Hematology
Latest News
The Most Misinterpreted Study in Medicine: Don’t be TRICCed
Misunderstood TRICC trial enrolled critical anemic patients stable after fluid resuscitation and not actively bleeding.
From the Journals
Unexplained collapse unveils rare blood disorder
Acquired TTP often appears to arise in connection with either an immune trigger, such as a viral infection, or immune dysregulation associated...
Latest News
Guide explains nonsurgical management of major hemorrhage
Bleeding affects everybody in medicine, from family doctors in smaller institutions who work in emergency departments to obstetricians and...
From the Journals
Factors linked with increased VTE risk in COVID outpatients
While the overall risk for VTE was low, age of at least 55 years, being male, and having a BMI of at least 30 and history of VTE increased the...
Feature
Doctors are disappearing from emergency departments as hospitals look to cut costs
It took three trips to the ED on 3 consecutive days before a patient saw a doctor who looked at her blood work.
From the Journals
VEXAS syndrome: More common, variable, and severe than expected
A large U.S. analysis found that this newly discovered genetic disease has a estimated prevalence of 1 in 4,269 in men older than 50.
Conference Coverage
EHR-based thromboembolism risk tool boosted prophylaxis
A thromboembolism risk calculator in a hospital’s EHR led to a significant rise in appropriate thromboprophylaxis and a drop in thromboembolic...
Latest News
Children with sickle cell anemia not getting treatments, screening
Annual screenings are recommended as is treatment with hydroxyurea, but only about half of affected children are getting lifesaving care.
Latest News
AAP guidance helps distinguish bleeding disorders from abuse
Laboratory testing of bleeding cannot always rule out abuse, just as a history of trauma may not rule out a bleeding disorder or other medical...
News
Blood type linked to higher risk for early onset stroke
“The risk of stroke due to blood type is smaller than other risk factors that we know about, like smoking and hypertension. I would be much more...
Conference Coverage
AXIOMATIC-SSP: Cautious optimism on factor XI inhibitor in stroke
The new factor XI inhibitor antithrombotic, milvexian, showed promising results in a dose-finding phase 2 trial in patients with acute ischemic...